In January, read Adocia’s article on M1Pram published in the Journal “Diabetes, Obesity and Metabolism”.

The scientific journal “Diabetes, Obesity and metabolism” has selected and published ADOCIA’s article dedicated to its product M1Pram (ADO09): “ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes”;

Authors:
Grit Andersen MD, Grégory Meiffren PhD, Susanne Famulla PhD, Tim Heise MD, Aymeric Ranson MSc, Cyril Seroussi MSc, Rosy Eloy MD, Martin Gaudier PhD, Richard Charvet PhD, You‐Ping Chan PhD, Olivier Soula PhD, J. Hans DeVries MD.

Link to the article:
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14302

Thanks to Adocia and Profil’s researchers, who are leading this ambitious and innovative project using bi-hormonal formulations dedicated to diabetes treatments.